S. D. Cohen

发表

A Survey of State PUC Activities to Incorporate Environmental Externalities into Electric Utility Planning and Regulation

C. Goldman, J. Eto, J. Beldock, 1990 .

Selective protein arylation by acetaminophen and 2,6-dimethylacetaminophen in cultured hepatocytes from phenobarbital-induced and uninduced mice. Relationship to cytotoxicity.

R. Birge, S. D. Cohen, J. Bartolone, 1989, Biochemical pharmacology.

Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.

J M Ward, Steven D. Cohen, J. Ward, 1998, Toxicology and applied pharmacology.

Environmental externalities: What state regulators are doing

J. H. Eto, Charles Goldman, J. Beldock, 1990 .

Immunochemical detection of acetaminophen-bound liver proteins.

Steven D. Cohen, S. D. Cohen, J. Bartolone, 1987, Biochemical pharmacology.

Selective acetaminophen metabolite binding to hepatic and extrahepatic proteins: an in vivo and in vitro analysis.

R. Birge, S. D. Cohen, J. Bartolone, 1989, Toxicology and applied pharmacology.

Acetaminophen-arylated proteins are detected in hepatic subcellular fractions and numerous extra-hepatic tissues in CD-1 and C57B1/6J mice.

S. D. Cohen, S. Bulera, E. Khairallah, 1996, Toxicology.

Mechanisms of toxicological interactions involving organophosphate insecticides.

S. D. Cohen, S. Cohen, 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Acetaminophen hepatotoxicity: correspondence of selective protein arylation in human and mouse liver in vitro, in culture, and in vivo.

Steven D. Cohen, R. Birge, S. D. Cohen, 1990, Toxicology and applied pharmacology.

A comparison of proteins S-thiolated by glutathione to those arylated by acetaminophen.

R. Birge, S. D. Cohen, J. Bartolone, 1991, Biochemical pharmacology.

A simplified bioassay for organophosphate detoxification and interactions.

S. D. Murphy, S. D. Cohen, S. Cohen, 1974, Toxicology and applied pharmacology.

Malathion potentiation and inhibition of hydrolysis of various carboxylic esters by triorthotolyl phosphate (TOTP) in mice.

S. D. Murphy, S. D. Cohen, S. Cohen, 1971, Biochemical pharmacology.

Carboxylesterase inhibition as an indicator of malathion potentiation in mice.

S. D. Murphy, S. D. Cohen, S. Cohen, 1971, The Journal of pharmacology and experimental therapeutics.

Parathion-induced suppression of humoral immunity in inbred mice.

S. D. Cohen, G. Casale, R. Dicapua, 1984, Toxicology letters.

Protection against acetaminophen hepatotoxicity by a single dose of clofibrate: effects on selective protein arylation and glutathione depletion.

J. Manautou, S. D. Cohen, E. Khairallah, 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins.

R. Birge, S. D. Cohen, J. Bartolone, 1988, Biochemical pharmacology.

Modulation of serum growth factor signal transduction in Hepa 1-6 cells by acetaminophen: an inhibition of c-myc expression, NF-kappaB activation, and Raf-1 kinase activity.

Steven D. Cohen, C. Giardina, S. D. Cohen, 1999, Toxicological sciences : an official journal of the Society of Toxicology.

Selective protein arylation and the age dependency of acetaminophen hepatotoxicity in mice.

S. D. Cohen, J. Bartolone, E. Khairallah, 1989, Toxicology and applied pharmacology.

Dissociation of covalent binding from the oxidative effects of acetaminophen. Studies using dimethylated acetaminophen derivatives.

Steven D. Cohen, R. Birge, S. D. Cohen, 1988, Biochemical pharmacology.

Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice.

U. Boelsterli, S. D. Cohen, F. Boess, 1998, Hepatology.

Relationship of skin conductance activity to clinical features in obsessive-compulsive ritualizers

P. Lelliott, I. Marks, S. D. Cohen, 1987, Psychological Medicine.

Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity.

Y. Liu, C. Klaassen, D. Hartley, 1999, The Journal of pharmacology and experimental therapeutics.

Evidence against deacetylation and for cytochrome P450-mediated activation in acetaminophen-induced nephrotoxicity in the CD-1 mouse.

S. D. Cohen, J. Bartolone, E. Khairallah, 1991, Toxicology and applied pharmacology.

Antidotal effectiveness of N-acetylcysteine in reversing acetaminophen-induced hepatotoxicity. Enhancement of the proteolysis of arylated proteins.

S. D. Cohen, E. Khairallah, M. Bruno, 1988, Biochemical pharmacology.

Effect of piperonyl butoxide post-treatment on acetaminophen hepatotoxicity.

S. D. Cohen, E. Khairallah, W. Beierschmitt, 1988, Biochemical pharmacology.

Steven D. Cohen, J. Manautou, S. D. Cohen, 1995, Toxicology and applied pharmacology.

Selective binding of acetaminophen (APAP) to liver proteins in mice and men.

Steven D. Cohen, R. Birge, C. Tyson, 1991, Advances in experimental medicine and biology.

Clofibrate pretreatment diminishes acetaminophen's selective covalent binding and hepatotoxicity.

J. Manautou, S. D. Cohen, D. Hoivik, 1994, Toxicology and applied pharmacology.

Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice.

Steven D. Cohen, S. D. Cohen, E. Khairallah, 1988, Toxicology and applied pharmacology.

Identification of the mouse liver 44-kDa acetaminophen-binding protein as a subunit of glutamine synthetase.

Steven D. Cohen, R. Birge, S. D. Cohen, 1995, Toxicology and applied pharmacology.

Protein arylation precedes acetaminophen toxicity in a dynamic organ slice culture of mouse kidney.

A. J. Gandolfi, S. D. Cohen, R. Fisher, 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Evidence for common binding of acetaminophen and bromobenzene to the 58-kDa acetaminophen-binding protein.

J. Manautou, S. D. Cohen, E. Khairallah, 1995, Journal of toxicology and environmental health.

Selective alterations in the patterns of newly synthesized proteins by acetaminophen and its dimethylated analogues in primary cultures of mouse hepatocytes.

S. D. Cohen, E. Khairallah, M. Bruno, 1992, Toxicology and applied pharmacology.

In vivo and in vitro evidence for in situ activation and selective covalent binding of acetaminophen (APAP) in mouse kidney.

R. Birge, R. Cartun, S. D. Cohen, 1991, Advances in experimental medicine and biology.

Post-treatment protection with piperonyl butoxide against acetaminophen hepatotoxicity is associated with changes in selective but not total covalent binding.

R. Birge, S. D. Cohen, E. Khairallah, 1991, Advances in experimental medicine and biology.

Protection against acetaminophen-induced hepatotoxicity by prior treatment with fenitrothion.

G. Ginsberg, S. D. Cohen, M. Placke, 1982, Toxicology and applied pharmacology.

Acetaminophen inhibits NF-kappaB activation by interfering with the oxidant signal in murine Hepa 1-6 cells.

Steven D. Cohen, C. Giardina, A. Boulares, 2000, Toxicological sciences : an official journal of the Society of Toxicology.

The effects of organophosphate-induced cholinergic stimulation on the antibody response to sheep erythrocytes in inbred mice.

Steven D. Cohen, S. D. Cohen, G. Casale, 1983, Toxicology and applied pharmacology.

Evidence suggesting the 58-kDa acetaminophen binding protein is a preferential target for acetaminophen electrophile.

J. Manautou, S. D. Cohen, D. Hoivik, 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Immunohistochemical localization of acetaminophen in target tissues of the CD-1 mouse: correspondence of covalent binding with toxicity.

Steven D. Cohen, R. Cartun, S. D. Cohen, 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.